Huang, J. J., Brooks, T., Romancik, J., Wang, M., Chong, E. A., Rao, U., Bachier, L., Mehta, A., Lunning, M. A., Bernasconi, D., Wang, L., Patel, K., Roy, D., Jaglowski, S. M., Hunter, B., Isufi, I. (2026). Outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): First real-world data from the CIBMTR.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7026